Kallistatin prevents ovarian hyperstimulation syndrome by regulating vascular leakage
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Cellular and Molecular Medicine"
DOI: 10.1111/jcmm.17491
Abstract: Angiogenesis and increased permeability are essential pathological basis for the development of ovarian hyperstimulation syndrome (OHSS). Kallistatin (KS) is an endogenous anti‐inflammatory and anti‐angiogenic factor that participates in a variety of diseases, but its role… read more here.
Keywords: kallistatin prevents; ovarian hyperstimulation; hyperstimulation syndrome; expression ... See more keywords